Pitt Shield

Microvascular and astrocytic responses to repeated magnetic resonance-guided focused ultrasound.

Authors: Rigollet S, Delphin A, Chalet L, Ador T, Dumont E, Lemasson B, Christen T, Pichon C, Delalande A, Stupar V, Barbier EL

Focused ultrasound (FUS), in combination with microbubbles, enables the transient and localized opening of the blood-brain barrier (BBB) for targeted drug delivery. While this technique has shown promise in preclinical models, the safety and neurovascular consequences of repeated BBB permeabilization remain incompletely understood. In this study, we performed a longitudinal assessment of vascular, microstructural, and glial responses following repeated FUS-mediated BBB opening in healthy rats using magnetic resonance (MR)-guided targeting and MR vascular fingerprinting. FUS sessions were conducted on a weekly or twice-weekly basis over a period of four weeks, employing two distinct acoustic pressures, 390 kPa and 440 kPa, respectively. The BBB opening was reproducible across sessions, with stable contrast enhancement observed with DCE-MRI and a homogeneous cumulative open BBB volume. No significant hemorrhages or edema were detected; however, transient cerebral blood flow reductions of approximately 15-20 % were observed following each session. After eight FUS sessions at 440 kPa, subtle vascular remodeling was observed, including increased vessel radius and reduced tissue oxygen saturation. This finding was confirmed by both MRI and histological analysis. Astrocytic activation, as determined by GFAP immunostaining, was minimal after a single or weekly FUS exposure but became significant with biweekly treatments, indicating a cumulative neuroimmune response. These results support the feasibility of weekly FUS-induced BBB opening at moderate acoustic pressures. However, they also underscore the importance of protocol optimization to prevent glial and vascular stress in long-term therapeutic applications.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To investigate the microvascular and astrocytic responses to repeated magnetic resonance-guided focused ultrasound.
Animal model / Human subject Forty-three Wistar Han rats from Janvier Labs
Disease model healthy
MRI or image guidance method Magnetic resonance-guided focused ultrasound (MRgFUS): a noninvasive acoustic energy-based experimental modality that delivers focused ultrasound to targeted brain regions under MRI guidance; used repeatedly to perturb microvascular and astrocytic physiology (specific sonication parameters not provided in the title).
Targeted brain region(s) Striatum
Target coordinates not reported
Cargo name and characteristics perfluorobutane gas
Route of administration intravenous

Outcomes and Safety

Summary of Outcomes Repeated MR-guided focused ultrasound produced microvascular alterations including increased permeability and blood–brain barrier disruption, accompanied by astrocytic activation (reactive gliosis).
Duration of biological effect Rats were euthanized
Safety-related matter No safety concerns or adverse effects are mentioned in the provided text.

Brain Region

Ultrasound Parameters

Ultrasound instrument MRgFUS system (Image Guided Therapy, Pessac, France)
FUS Frequency 1.5 MHz
FUS Intensity Not reported in provided text
FUS Pressure 40 kPa
FUS Mode Continuous
Pulse duration not reported
Duration of a single FUS session 34 s.
Focal Characteristics radius of curvature: 20.01 mm
Treatment frequency multiple sessions

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search